ephedrine has been researched along with Genetic Predisposition in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nielsen, HB; Nielsen, M; Olsen, NV; Secher, NH; Staalsoe, JM; Ullum, H | 1 |
| Giovanella, L; July, M; Santhanam, P; Treglia, G | 1 |
| Allen, D; Arunachalam, R; Beeson, D; Burke, G; Hammans, S | 1 |
| Beeson, D; Jayawant, S; Lashley, D; Palace, J; Robb, S | 1 |
| Bestue-Cardiel, M; Capablo-Liesa, JL; Engel, AG; López-Pisón, J; Martin-Martinez, J; Peña-Segura, JL; Sáenz de Cabezón-Alvarez, A | 1 |
1 review(s) available for ephedrine and Genetic Predisposition
| Article | Year |
|---|---|
Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes.
Topics: 5-Hydroxytryptophan; Biomarkers, Tumor; Dihydroxyphenylalanine; Ephedrine; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Methionine; Multiple Endocrine Neoplasia; Mutation; Phenotype; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin | 2018 |
1 trial(s) available for ephedrine and Genetic Predisposition
| Article | Year |
|---|---|
Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
Topics: Cohort Studies; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Ephedrine; Follow-Up Studies; Genetic Predisposition to Disease; Genetic Testing; Humans; Muscle Proteins; Muscle Strength; Muscle, Skeletal; Mutation; Myasthenic Syndromes, Congenital; Outcome Assessment, Health Care; Patient Selection; Prospective Studies; Recovery of Function; Sympathomimetics; Treatment Outcome | 2010 |
3 other study(ies) available for ephedrine and Genetic Predisposition
| Article | Year |
|---|---|
The Gly16 Allele of the Gly16Arg Single-Nucleotide Polymorphism in the β₂-Adrenergic Receptor Gene Augments Perioperative Use of Vasopressors: A Retrospective Cohort Study.
Topics: Adult; Aged; Anesthesia, General; Arterial Pressure; Denmark; DNA Mutational Analysis; Elective Surgical Procedures; Ephedrine; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Haplotypes; Heterozygote; Homozygote; Humans; Hypotension; Male; Middle Aged; Neurosurgical Procedures; Pharmacogenetics; Phenotype; Phenylephrine; Polymorphism, Single Nucleotide; Receptors, Adrenergic, beta-2; Retrospective Studies; Risk Factors; Vasoconstrictor Agents; White People | 2016 |
A treatable muscle disease.
Topics: Age Distribution; Aged; Disease Progression; Ephedrine; Extremities; Female; Gait Disorders, Neurologic; Genetic Predisposition to Disease; Horner Syndrome; Humans; Muscle Proteins; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Myasthenic Syndromes, Congenital; Neuromuscular Junction | 2009 |
Congenital endplate acetylcholinesterase deficiency responsive to ephedrine.
Topics: Acetylcholinesterase; Adolescent; Adrenergic Agents; Child; Cholinesterase Inhibitors; Diagnosis, Differential; DNA Mutational Analysis; Electromyography; Ephedrine; Female; Genetic Predisposition to Disease; Humans; Male; Muscle, Skeletal; Mutation; Myasthenic Syndromes, Congenital; Neostigmine; Neuromuscular Junction; Protein Structure, Tertiary; Synaptic Transmission | 2005 |